HER2-低乳腺癌-当前知识和未来方向
Abeer M Shaaban1,2, Tanvier Kaur3, Elena Provenzano4,5
1Department of Cellular Pathology, Queen Elizabeth Hospital Birmingham, Birmingham B15 2GW, UK.
Medicina (Kaunas, Lithuania)
|April 26, 2025
概括
乳腺癌中HER2状态的传统二进制分类正在演变. 新数据显示,抗体-药物合物 (ADC) 有益于HER2-低乳腺癌患者,挑战了先前的定义.
科学领域:
- 在瘤学瘤学.
- 翻译研究是翻译研究.
- 生物标志物发现发现
背景情况:
- 乳腺癌中HER2 (人类表皮生长因子受体2) 状态的二进制分类正在重新评估中.
- 在DESTINY-Breast试验中,在HER2-低表达的侵入性乳腺癌患者中,抗体-药物合物 (ADC) 的有效性显著.
- 低HER2的乳腺癌是通过免疫组织化学 (IHC) 评分1+或2+而没有HER2基因放大来定义的.
研究的目的:
- 提供对HER2-低和HER2-超低乳腺癌的最新审查.
- 讨论最近临床试验数据对HER2分类的影响.
- 探索乳腺癌中HER2表达的不断变化的情况.
主要方法:
- 对关键临床试验的文献综述,重点是DESTINY-Breast.
- 分析HER2-低和HER2-超低乳腺癌的定义和特征.
- 讨论当前的临床指南和质量控制问题.
主要成果:
- 抗体药物合物 (ADC) 在低HER2乳腺癌中显示出临床益处,扩大了治疗选择,超出了HER2阳性疾病.
- 低HER2乳腺癌不是一个独特的生物实体,而是包括激素受体阳性和三阴性亚型.
- 在HER2-低和HER2-零乳腺癌之间存在临床行为和反应的差异.
结论:
- 乳腺癌中HER2表达的定义和临床意义正在扩展到传统的二进制分类之外.
- 低HER2状态代表了像ADCs这样的新型药物的关键治疗标.
- 需要进一步的研究和标准化,以优化 HER2-low 和 HER2-ultralow 乳腺癌患者的鉴定和治疗.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cancer Vaccines
238
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
238


